Equities
Health CareHealth Care Providers
  • Price (HKD)2.00
  • Today's Change-0.02 / -0.99%
  • Shares traded137.00k
  • 1 Year change+124.72%
  • Beta1.3393
Data delayed at least 15 minutes, as of Feb 06 2026 08:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Yonghe Medical Group Co Ltd is a holding company specializing in hair-related healthcare services. The Company offers one-stop hair-related healthcare services covering hair transplant, medical hair care, routine hair restoration and other ancillary services. The Company has built a brand matrix for the full industry chain which is centered on Yonghe Medical and comprised of Yonghe Hair Transplant for professional hair transplant service, Svenson for medical hair care service, Yonghe Fa Zhi Chu for female aesthetic hair transplant service, and Harvard for medical wig products. The Company also provides medical-grade hair health management service for patients facing hair diseases in a way using medical testing, diagnosis and personalized nursing treatment through Svenson Medical Hair Care Centers. The Company mainly conducts its businesses in domestic market.

  • Revenue in HKD (TTM)1.99bn
  • Net income in HKD-69.81m
  • Incorporated2020
  • Employees3.23k
  • Location
    Yonghe Medical Group Co LtdChina Nuclear E&C Building11/F,20 Ganluyuan NanliChaoyang DistrictBEIJING 100020ChinaCHN
  • Websitehttps://www.yonghegroup.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Guangdong Kanghua Healthcare G2.31bn86.12m568.47m3.84k6.600.3482.380.24610.25750.25756.914.880.75524.847.54534,760.102.491.103.621.5816.2716.223.301.501.228.250.196518.940.67641.00-87.33-27.06-16.86--
Wenzhou Kangning Hospital Co Ltd1.76bn57.87m694.65m4.76k12.110.49883.970.39470.79270.792724.0219.240.516623.123.60361,482.601.061.651.412.3524.9625.012.063.001.302.950.48827.533.6313.96-23.662.758.54--
Hospital Corporation of China Ltd1.65bn150.59m710.32m1.84k7.381.242.850.43060.69630.69639.764.140.581733.4911.49896,088.106.23-7.389.62-13.4518.4421.7910.70-22.911.501.310.5842--1.0228.55-129.40--5.58--
Xikang Cloud Hospital Holdings Inc563.72m-81.46m724.01m834.00--2.00--1.28-0.0968-0.09680.66960.4310.428317.354.68659,316.10-6.27---17.21--28.80---14.64--1.17-1.530.6159---6.74--46.30------
China Biotech Services Holdings Ltd76.93m-150.24m731.80m133.00--3.06--9.51-0.1542-0.15420.07890.24490.131618.151.48545,617.00-27.8714.54-40.8325.610.921653.53-211.7117.960.17-1.930.50180.00-66.743.55-107.60--47.69--
MedSci Healthcare Holdings Ltd309.72m42.72m813.61m451.0016.960.612816.332.630.0790.0790.57282.190.2038--2.58634,680.202.81--3.26--62.40--13.79----259.060.007---25.36---54.64------
EuroEyes International Eye Clinic Ltd724.44m76.53m878.73m354.0011.610.69484.511.210.2360.2362.233.940.411325.2258.052,249,798.004.456.735.157.7140.7845.1110.8315.813.7443.880.2123.550.19510.74-37.30--22.47--
Honliv Healthcare Management Grp Co Ltd788.22m11.75m990.00m1.84k77.201.5917.501.260.02140.02141.441.040.742231.0113.20403,180.001.123.811.846.7614.4020.151.505.280.97882.700.19530.001.087.68-18.69-8.80-4.52--
Tian An Medicare Ltd1.59bn19.09m1.01bn2.69k52.840.55388.350.63260.01760.01761.461.680.45924.6013.12605,027.400.7986-1.661.16-2.5619.6318.931.74-3.890.95112.430.3139--3.72--96.03------
Arrail Group Ltd1.90bn24.75m1.03bn3.11k33.930.42593.470.54130.05390.05394.114.300.526521.1416.49610,791.600.5042-10.490.7175-28.7920.2620.910.9576-18.491.8410.490.3655---3.298.9528.13---0.2469--
Yonghe Medical Group Co Ltd1.99bn-69.81m1.06bn3.23k--1.274.450.5339-0.1362-0.13623.941.590.954215.44218.61559,972.40-3.25-5.01-4.69-6.6862.5865.39-3.40-6.541.320.53270.4126--1.538.0657.92---13.04--
Concord Healthcare Group Co Ltd416.66m-492.88m1.10bn573.00--0.5939--2.63-0.6869-0.68690.58012.360.064415.046.79734,846.90-8.40---11.28---8.74---130.41--0.5112-3.170.6384---27.91---18.80------
BenQ BM Holding Cayman Corp2.97bn106.04m1.17bn3.65k11.060.62563.830.39460.34000.34009.536.01----------------16.43--3.57--0.341410.710.3229---1.07---34.95------
Kindstar Globalgene Technology Inc1.03bn-115.42m1.25bn3.16k--0.3832--1.22-0.122-0.1221.083.160.23568.931.67340,565.10-2.69-16.49-3.46-22.4545.0347.57-11.40-46.462.57-5.800.1417---4.102.18-232.22--26.54--
Rici Healthcare Holdings Ltd3.19bn301.92m1.54bn8.36k5.110.97852.050.4830.18990.18992.010.99130.61349.7910.70358,564.807.505.3612.629.5141.5438.9112.249.540.84085.380.61310.00-2.2811.12-18.27---8.12--
Data as of Feb 06 2026. Currency figures normalised to Yonghe Medical Group Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.80%Per cent of shares held by top holders
HolderShares% Held
FIL Investment Management (Hong Kong) Ltd.as of 31 Oct 20253.86m0.74%
Velten Asset Management GmbHas of 31 Oct 2025267.21k0.05%
Lazard Asset Management LLCas of 31 Dec 202548.50k0.01%
China Universal Asset Management Co., Ltd.as of 30 Jun 20250.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.